FEDSYRA Trademark

Trademark Overview

On Friday, March 4, 2022, a trademark application was filed for FEDSYRA with the United States Patent and Trademark Office. The USPTO has given the FEDSYRA trademark a serial number of 97297070. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Monday, March 17, 2025. This trademark is owned by AcelRx Pharmaceuticals, Inc.. The FEDSYRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for use in the treatment of cardio-vascular disorders, hypotension, and disorders arising in the course or as a result of general anesthesia

General Information

Serial Number97297070
Word MarkFEDSYRA
Filing DateFriday, March 4, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateMonday, March 17, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 1, 2023

Trademark Statements

Goods and ServicesPharmaceuticals for use in the treatment of cardio-vascular disorders, hypotension, and disorders arising in the course or as a result of general anesthesia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 9, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTALPHERA, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressSAN MATEO, CA 94404
Party NameAcelRx Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHayward, CA 94545
Party NameAcelRx Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHayward, CA 94545

Trademark Events

Event DateEvent Description
Wednesday, December 21, 2022NON-FINAL ACTION WRITTEN
Tuesday, March 8, 2022NEW APPLICATION ENTERED
Wednesday, March 9, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 15, 2022ASSIGNED TO EXAMINER
Wednesday, December 21, 2022NON-FINAL ACTION E-MAILED
Wednesday, December 21, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 21, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, March 21, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, June 20, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 20, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 21, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 26, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, July 12, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 1, 2023PUBLISHED FOR OPPOSITION
Tuesday, August 1, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, January 18, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 24, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, January 16, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, January 16, 2024SOU EXTENSION 1 FILED
Tuesday, January 16, 2024SOU EXTENSION 1 GRANTED
Thursday, September 5, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 19, 2024SOU TEAS EXTENSION RECEIVED
Thursday, September 19, 2024SOU EXTENSION 2 GRANTED
Thursday, September 19, 2024SOU EXTENSION 2 FILED
Thursday, September 5, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, September 5, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 5, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, September 5, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 5, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, September 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 17, 2025SOU TEAS EXTENSION RECEIVED
Monday, March 17, 2025SOU EXTENSION 3 FILED
Tuesday, March 18, 2025SOU EXTENSION 3 GRANTED
Tuesday, March 18, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

fedsyra disorders course result general anesthesia arising hypotension treatment cardio vascular